{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T20:42:32Z","timestamp":1781124152667,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T00:00:00Z","timestamp":1618358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Over the last decade, the use of proteomics in the setting of prematurity has increased and has enabled researchers to successfully identify biomarkers for an array of associated morbidities. The objective of this scoping review was to identify the existing literature, as well as any knowledge gaps related to proteomic biomarker discoveries in the setting of prematurity. A scoping review was conducted using PubMed, Embase and Medline databases following the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The study selection process yielded a total of 700 records, of which 13 studies were included in this review. Most studies used a tandem Mass Spectrometry (MS\/MS) proteomics approach to identify key biomarkers. The corresponding studies identified proteins associated with retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD), necrotising enterocolitis (NEC), late onset sepsis (LOS) and gestational age. This scoping review demonstrates the limited use of proteomics to identify biomarkers associated with severe complications of prematurity. Further research is warranted to identify biomarkers of other important morbidities associated with prematurity, such as intraventricular haemorrhage (IVH) and cerebral palsy, and to investigate the mechanisms associated with these outcomes.<\/jats:p>","DOI":"10.1186\/s12014-021-09316-y","type":"journal-article","created":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T20:29:27Z","timestamp":1618432167000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The use of proteomics for blood biomarker research in premature infants: a scoping review"],"prefix":"10.1186","volume":"18","author":[{"given":"Natasha","family":"Letunica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengyi","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanie L. Y.","family":"Cheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lex W.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Monagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Ignjatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,14]]},"reference":[{"issue":"3","key":"9316_CR1","first-page":"325","volume":"6","author":"M Ahram","year":"2008","unstructured":"Ahram M, Petricoin EF. Proteomics discovery of disease biomarkers. Biomark Insights. 2008;6(3):325\u201333.","journal-title":"Biomark Insights"},{"issue":"6","key":"9316_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1097\/PPO.0b013e3182383cab","volume":"17","author":"S Hanash","year":"2011","unstructured":"Hanash S, Taguchi A. Application of Proteomics to Cancer Early Detection. Cancer J. 2011;17(6):423\u20138.","journal-title":"Cancer J"},{"issue":"6","key":"9316_CR3","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1053\/j.ackd.2010.09.001","volume":"17","author":"ML Merchant","year":"2010","unstructured":"Merchant ML, Klein JB. Proteomic discovery of diabetic nephropathy biomarkers. Adv Chronic Kidney Dis. 2010;17(6):480\u20136.","journal-title":"Adv Chronic Kidney Dis"},{"issue":"12","key":"9316_CR4","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.1021\/acs.jproteome.9b00503","volume":"18","author":"V Ignjatovic","year":"2019","unstructured":"Ignjatovic V, Geyer PE, Palaniappan KK, Chaaban JE, Omenn GS, Baker MS, et al. Mass spectrometry-based plasma proteomics: considerations from sample collection to achieving translational data. J Proteome Res. 2019;18(12):4085\u201397.","journal-title":"J Proteome Res"},{"issue":"23","key":"9316_CR5","doi-asserted-by":"publisher","first-page":"6326","DOI":"10.1002\/pmic.200600284","volume":"6","author":"S Hu","year":"2006","unstructured":"Hu S, Loo JA, Wong DT. Human body fluid proteome analysis. Proteomics. 2006;6(23):6326\u201353.","journal-title":"Proteomics"},{"issue":"1","key":"9316_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/ijgo.13195","volume":"150","author":"SR Walani","year":"2020","unstructured":"Walani SR. Global burden of preterm birth. Int J Gynecol Obstet. 2020;150(1):31\u20133.","journal-title":"Int J Gynecol Obstet"},{"issue":"3","key":"9316_CR7","doi-asserted-by":"publisher","first-page":"101114","DOI":"10.1016\/j.siny.2020.101114","volume":"25","author":"JLY Cheong","year":"2020","unstructured":"Cheong JLY, Spittle AJ, Burnett AC, Anderson PJ, Doyle LW. Have outcomes following extremely preterm birth improved over time? Semin Fetal Neonatal Med. 2020;25(3):101114.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"6","key":"9316_CR8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1213\/ANE.0000000000000705","volume":"120","author":"HC Glass","year":"2015","unstructured":"Glass HC, Costarino AT, Stayer SA, Brett CM, Cladis F, Davis PJ. Outcomes for extremely premature infants. Anesth Analg. 2015;120(6):1337\u201351.","journal-title":"Anesth Analg"},{"issue":"3","key":"9316_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1159\/000353721","volume":"104","author":"R Murgas Torrazza","year":"2013","unstructured":"Murgas Torrazza R, Li N, Young C, Kobeissy F, Chow M, Chen S, et al. Pilot study using proteomics to identify predictive biomarkers of necrotizing enterocolitis from buccal swabs in very low birth weight infants. Neonatology. 2013;104(3):234\u201342.","journal-title":"Neonatology"},{"issue":"13","key":"9316_CR10","doi-asserted-by":"publisher","first-page":"5312","DOI":"10.1167\/iovs.18-24914","volume":"59","author":"M Zasada","year":"2018","unstructured":"Zasada M, Suski M, Bokiniec R, Szwarc-Duma M, Borszewska-Kornacka MK, Madej J, et al. An iTRAQ-based quantitative proteomic analysis of plasma proteins in preterm newborns with retinopathy of prematurity. Investig Opthalmology Vis Sci. 2018;59(13):5312.","journal-title":"Investig Opthalmology Vis Sci"},{"issue":"7","key":"9316_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467.","journal-title":"Ann Intern Med"},{"issue":"3","key":"9316_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/pr.2015.235","volume":"79","author":"CJ Stewart","year":"2016","unstructured":"Stewart CJ, Nelson A, Treumann A, Skeath T, Cummings SP, Embleton ND, et al. Metabolomic and proteomic analysis of serum from preterm infants with necrotising entercolitis and late-onset sepsis. Pediatr Res. 2016;79(3):425\u201331.","journal-title":"Pediatr Res"},{"issue":"1","key":"9316_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41390-018-0003-2","volume":"84","author":"M Suski","year":"2018","unstructured":"Suski M, Bokiniec R, Szwarc-Duma M, Madej J, Bujak-Gizycka B, Kwinta P, et al. Prospective plasma proteome changes in preterm infants with different gestational ages. Pediatr Res. 2018;84(1):104\u201311.","journal-title":"Pediatr Res"},{"issue":"9","key":"9316_CR14","first-page":"1182","volume":"38","author":"M Suski","year":"2018","unstructured":"Suski M, Bokiniec R, Szwarc-Duma M, Madej J, Bujak-Gizycka B, Borszewska-Kornacka MK, et al. Plasma proteome changes in cord blood samples from preterm infants. J Perinatol Off J Calif Perinat Assoc. 2018;38(9):1182\u20139.","journal-title":"J Perinatol Off J Calif Perinat Assoc"},{"issue":"1","key":"9316_CR15","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13052-019-0676-0","volume":"45","author":"M Zasada","year":"2019","unstructured":"Zasada M, Suski M, Bokiniec R, Szwarc-Duma M, Borszewska-Kornacka MK, Madej J, et al. Comparative two time-point proteome analysis of the plasma from preterm infants with and without bronchopulmonary dysplasia. Ital J Pediatr. 2019;45(1):112.","journal-title":"Ital J Pediatr"},{"issue":"8","key":"9316_CR16","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1172\/JCI40196","volume":"120","author":"PC Ng","year":"2010","unstructured":"Ng PC, Ang IL, Chiu RWK, Li K, Lam HS, Wong RPO, et al. Host-response biomarkers for diagnosis of late-onset septicemia and necrotizing enterocolitis in preterm infants. J Clin Invest. 2010;120(8):2989\u20133000.","journal-title":"J Clin Invest"},{"issue":"101475056","key":"9316_CR17","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jprot.2015.02.003","volume":"119","author":"MD Ruis-Gonzalez","year":"2015","unstructured":"Ruis-Gonzalez MD, Canete MD, Gomez-Chaparro JL, Abril N, Canete R, Lopez-Barea J. Alterations of protein expression in serum of infants with intrauterine growth restriction and different gestational ages. J Proteomics. 2015;119(101475056):169\u201382.","journal-title":"J Proteomics"},{"issue":"11","key":"9316_CR18","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.1167\/iovs.16-19653","volume":"57","author":"AM Lynch","year":"2016","unstructured":"Lynch AM, Wagner BD, Mandava N, Palestine AG, Mourani PM, McCourt EA, et al. The relationship of novel plasma proteins in the early neonatal period with retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2016;57(11):5076\u201382.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"9316_CR19","doi-asserted-by":"publisher","first-page":"L644","DOI":"10.1152\/ajplung.00131.2019","volume":"318","author":"S Arjaans","year":"2020","unstructured":"Arjaans S, Wagner BD, Mourani PM, Mandell EW, Poindexter BB, Berger RMF, et al. Early angiogenic proteins associated with high risk for bronchopulmonary dysplasia and pulmonary hypertension in preterm infants. Am J Physiol Lung Cell Mol Physiol. 2020;318(4):L644\u201354.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"9316_CR20","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/ajrccm.164.1.2008022","volume":"164","author":"PL Ramsay","year":"2001","unstructured":"Ramsay PL, DeMAYO FJ, Hegemier SE, Wearden ME, Smith CV, Welty SE. Clara cell secretory protein oxidation and expression in premature infants who develop bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2001;164(1):155\u201361.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"9316_CR21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1164\/rccm.201703-0654LE","volume":"197","author":"BD Wagner","year":"2018","unstructured":"Wagner BD, Babinec AE, Carpenter C, Gonzalez S, O\u2019Brien G, Rollock K, et al. Proteomic profiles associated with early echocardiogram evidence of pulmonary vascular disease in preterm infants. Am J Respir Crit Care Med. 2018;197(3):394\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"9316_CR22","doi-asserted-by":"publisher","first-page":"942","DOI":"10.15252\/msb.20156297","volume":"13","author":"PE Geyer","year":"2017","unstructured":"Geyer PE, Holdt LM, Teupser D, Mann M. Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol. 2017;13(9):942.","journal-title":"Mol Syst Biol"},{"issue":"3","key":"9316_CR23","doi-asserted-by":"publisher","first-page":"e255","DOI":"10.1542\/peds.2004-1837","volume":"115","author":"MC Byung","year":"2005","unstructured":"Byung MC, Kee HL, Baik LE, Kee HY, Young SH, Chang SS, et al. Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics. 2005;115(3):e255\u201361.","journal-title":"Pediatrics"},{"issue":"16","key":"9316_CR24","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1080\/14767058.2018.1560411","volume":"33","author":"AMS Tosson","year":"2020","unstructured":"Tosson AMS, Glaser K, Weinhage T, Foell D, Aboualam MS, Edris AA, et al. Evaluation of the S100 protein A12 as a biomarker of neonatal sepsis. J Matern Fetal Neonatal Med. 2020;33(16):2768\u201374.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"9316_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41390-020-0912-8","author":"W Zhong","year":"2020","unstructured":"Zhong W, Danielsson H, Tebani A, Karlsson MJ, Elfvin A, Hellgren G, et al. Dramatic changes in blood protein levels during the first week of life in extremely preterm infants. Pediatr Res. 2020. https:\/\/doi.org\/10.1038\/s41390-020-0912-8.","journal-title":"Pediatr Res."}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-021-09316-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-021-09316-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-021-09316-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,14]],"date-time":"2021-04-14T20:29:31Z","timestamp":1618432171000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-021-09316-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,14]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["9316"],"URL":"https:\/\/doi.org\/10.1186\/s12014-021-09316-y","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,14]]},"assertion":[{"value":"17 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}